Covid-19 roundup: Temasek leads a $250M raise for BioN­Tech as first Covid-19 mR­NA vac­cine da­ta looms; Chi­na's mil­i­tary OKs first use of coro­n­avirus vac­cine

Sin­ga­pore’s gi­ant fund run by Temasek is putting some fi­nan­cial mus­cle be­hind BioN­Tech $BN­TX as the Pfiz­er part­ner pre­pares to post the first cut of its da­ta on their mR­NA vac­cine to com­bat Covid-19.

Temasek is lead­ing a $250 mil­lion in­jec­tion in­to the Ger­man biotech, one of a small pack of mR­NA play­ers at­tempt­ing to field a vac­cine to fight the glob­al pan­dem­ic that’s been rat­tling the world. Mod­er­na is in front of the mR­NA pack with Phase III plans.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.